12 employees
Neurosteer® offers a wearable device for the early detection and treatment of a variety of neurological disorders, including Alzheimer’s.
2015
$83K
from 1 investors over 1 rounds
Neurosteer raised $83K on September 1, 2018
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)